Diffuse Large B-Cell Non-Hodgkin’s Lymphoma (DLBCL- NHL)

Sep 20, 2016 by in HEMATOLOGY Comments Off on Diffuse Large B-Cell Non-Hodgkin’s Lymphoma (DLBCL- NHL)

(a) Diffuse large B-cell lymphoma (DLBCL), NOS T-cell/histiocyte rich large B-cell lymphoma (T/HRBCL) EBV + DLBCL of the “elderly” (b) DLBCL with a predominant extranodal location Primary mediastinal (thymic) large B cell…

read more

Multiple Myeloma

Sep 20, 2016 by in HEMATOLOGY Comments Off on Multiple Myeloma

Adverse event Novel agent Action Dose-reductions Neutropenia Lenalidomide, Bortezomib G-CSF until neutrophil recovery in case of uncomplicated grade 4 or grade 2–3 complicated by fever or infection. 25–50 % drug…

read more

Indolent Lymphomas in Older Patients

Sep 20, 2016 by in HEMATOLOGY Comments Off on Indolent Lymphomas in Older Patients

Small lymphocytic lymphoma/ chronic lymphocytic leukemia B-cell prolymphocytic leukemia Splenic marginal zone lymphoma Hairy cell leukemia Splenic B–cell lymphoma/leukemia unclassifiable a Splenic red pulp small B–cell lymphoma a Hairy cell…

read more

Chronic Lymphocytic Leukemia (CLL)

Sep 20, 2016 by in HEMATOLOGY Comments Off on Chronic Lymphocytic Leukemia (CLL)

Fig. 7.1 Age-distribution among patients with newly diagnosed CLL Biology and Aging The etiology of CLL is unknown and its pathogenesis is not fully understood [2]. The reason why CLL…

read more

Antibacterial Agents

Sep 20, 2016 by in HEMATOLOGY Comments Off on Antibacterial Agents

Dosing regimen Duration of infusion (h) MIC (μg/mL) Probability of patients achieving a target T > MIC of 30 % 35 % 40 % 45 % 500 mg every 8…

read more

Central Nervous System Infections

Sep 20, 2016 by in HEMATOLOGY Comments Off on Central Nervous System Infections

Fig. 13.1 Algorithm to diagnose and to treat empirically/preemptively CNS infections in hematology patients Lumbar puncture and cerebrospinal fluid (CSF) analysis should follow the algorithm in Fig. 13.1 and are…

read more

Myeloid Growth Factors

Sep 20, 2016 by in HEMATOLOGY Comments Off on Myeloid Growth Factors

Tumor FN-Risk (%) Regimen Breast cancer >20 AC docetaxel, doxorubicin/docetaxel, doxorubicin/paclitaxel, TAC 10–20 AC, EC, docetaxel, FE120C (q4 weeks), CEF <10 CMF Colon cancer 10–20 5-FU/folinic acid FOLFIRI (5-FU/folinic acid/irinotecan)…

read more

Pulmonary Complications

Sep 20, 2016 by in HEMATOLOGY Comments Off on Pulmonary Complications

Fig. 10.1 Diagnostic procedures and treatment of neutropenic patients with fever and suspected or proven lung infiltrates. CT computed tomography, BAL bronchoalveolar lavage. Dotted lines indicate exceptions from recommended procedure…

read more
Get Clinical Tree app for offline access